Why the ResMed Inc. share price just hit another record high

The share price of sleep treatment specialist ResMed Inc. (ASX:RMD) hit a record high of $16.52 in Tuesday trade before retreating to close up 0.2% to $16.36.

Shareholders of the Australian listed scrip have seen their shares appreciate 48% over the last 12 months, comfortably outperforming the broader market’s loss of 2%. The impressive rise has been a result of strong earnings growth from the expansion of the company’s product portfolio with new masks and ongoing upgrades to its digital health solutions driving revenue growth. Effective cost control has also boosted the bottom line.

Furthermore, the falling Australian dollar has lifted the share price of the Australian listed scrip as it represents a 1/10th ownership interest in the NYSE scrip where the company has its primary listing.

Focus will now shift towards ResMed’s Q2 2019 earnings report that is scheduled for release on Friday morning. The current earnings per share consensus estimate for the quarter is 92 US cents per The Wall Street Journal.

ResMed and other healthcare stocks such as CSL Limited (ASX:CSL) and Cochlear Limited (ASX:COH) have some of the best prospects for solid long-term growth at the larger end of the Australian market that is heavily weighted towards the large banks and other mature businesses.

JUST RELEASED: Our Top 3 Dividend Bets for 2019

NEW! The Motley Fool’s team of crack analysts has just released a timely report revealing the names and codes of their top 3 dividend share recommendations for 2019. Be among the first investors to get access—FREE, for a strictly limited time. You’ll discover the names of 3 hefty dividend paying companies with what our analysts consider to be solid growth prospects for the year ahead…

The first two currently offer fat, fully franked yields and the third is a surprising REIT offering you the chance to become a landlord with none of the hassle! If you’re looking for hot new ideas, look no further. But you do need to hurry. Snap up your free copy now, before supplies run out!

Simply click here to grab your FREE copy of this up-to-the-minute research report on our top 3 dividend share recommendations right away.

Motley Fool contributor Tim Katavic owns shares in ResMed Inc. The Motley Fool Australia has recommended ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

5 ASX Stocks for Building Wealth After 50

I just read that Warren Buffett, the world’s best investor, made over 99% of his massive fortune after his 50th birthday.

It just goes to show you… it’s never too late to start securing your financial future.

And Motley Fool Chief Investment Advisor Scott Phillips just released a brand-new report that reveals five of our favourite ASX stocks for building wealth after 50.

– Each company boasts strong growth prospects over the next 3 to 5 years…

– Most importantly each pays a generous dividend, fully franked.

Simply click here to find out how you can claim your FREE copy of “5 ASX Stocks for Building Wealth After 50.”

See the stocks now